Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Always verify the actual mg breakdown on the vial label before reconstituting - supplier brand names vary
Roivant Sciences to Discontinue RVT-2001 Development in Myelodysplastic Syndrome Development of the investigational SF3B1 modulator RVT-2001 (previously H3B-8800) will be discontinued based on findings from an interim analysis of the phase 1/2 Encore-MDS trial (NCT02841540) in patients with myelodysplastic syndrome (MDS), according to an announcement from developer Roivant Sciences
The twice weekly dosing also helped eliminate the drop-off in the medications effectiveness toward the end of the week
Why the amount of bacteriostatic water matters Reconstitution is not just about dissolving powder
US$ 25.98
US$ 28.25
US$ 28.32
